Related references
Note: Only part of the references are listed.Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis
Rebecca A. Nelson et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study
E. A. Rakha et al.
BRITISH JOURNAL OF CANCER (2015)
Metaplastic Breast Carcinoma: a Heterogeneous Disease
Melis Gultekin et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Metaplastic carcinoma of the breast: an immunohistochemical study
Fadwa J. Altaf et al.
DIAGNOSTIC PATHOLOGY (2014)
Molecular Classification of Metaplastic Carcinoma Using Surrogate Immunohistochemical Staining
Hye Min Kim et al.
PATHOBIOLOGY (2014)
Current Progress in the Treatment of Metaplastic Breast Carcinoma
Qing Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The prognostic significance of metaplastic carcinoma of the breast (MCB) - A case controlled comparison study with infiltrating ductal carcinoma
Hung-Wen Lai et al.
BREAST (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators
Yanni Song et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Metaplastic Breast Carcinoma: Case Series and Review of the Literature
Onur Esbah et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers
T. R. Lester et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metaplastic breast cancer: clinicopathological features and its prognosis
Hyewon Lee et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Metaplastic Breast Cancer: To Radiate or Not to Radiate?
Warren H. Tseng et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients
Soo Youn Bae et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity
Kyu-Hyoung Lim et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinicopathologic Features and Outcomes of Metaplastic Breast Carcinoma: Comparison with Invasive Ductal Carcinoma of the Breast
Hyung Seok Park et al.
YONSEI MEDICAL JOURNAL (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy
Judith A. Gilbert et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature
Alberto Luini et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes
Mi-Jung Kim et al.
HUMAN PATHOLOGY (2006)
Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factors
AD Al Sayed et al.
ACTA ONCOLOGICA (2006)
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
JS Reis et al.
BREAST CANCER RESEARCH (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Targeting epidermal growth factor receptor - are we missing the mark?
JE Dancey et al.
LANCET (2003)
Share Paper
